CD163 and breast carcinoma: In the overall study population, CD163+ macrophage density was significantly associated with age (p = 0.025), breast cancer subtype (p < 0.001), stage (p < 0.001), grade (p < 0.001), and tumor size (p = 0.002); similar associations were observed when the Black population was examined separately (Table 2).